|
|
发表于 15-3-2021 08:18 AM
|
显示全部楼层
本帖最后由 icy97 于 16-8-2021 07:41 AM 编辑
Particulars of substantial Securities HolderName | CITA REALITI SDN BHD | Address | Lot A-2-3A, 2nd Floor,
Melawati Corporate Centre,
Taman Melawati,
Kuala Lumpur
53300 Wilayah Persekutuan
Malaysia. | Company No. | 201801010137 (1272152-A) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 20 Oct 2020 | 23,874,500 | Disposed | Direct Interest | Name of registered holder | CITA REALITI SDN BHD | Address of registered holder | LOT A-2-3A, 2ND FLOOR, MELAWATI CORPORATE CENTRE, TAMAN MELAWATI, 53300 KUALA LUMPUR, WILAYAH PERSEKUTUAN | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of shares via open market. | Nature of interest | Direct Interest | Direct (units) | 137,561,885 | Direct (%) | 11.042 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 137,561,885 | Date of notice | 23 Oct 2020 | Date notice received by Listed Issuer | 23 Oct 2020 |
Date of change | 12 Nov 2020 | Name | DATUK TAN CHOON HWA | Age | 63 | Gender | Male | Nationality | Malaysia | Designation | Deputy Chairman | Directorate | Independent and Non Executive | Type of change | Appointment |
QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | | 1 | Others | N/A | N/A | High School Education |
Working experience and occupation | Datuk Tan is a businessman with twenty (20) years of experience in various industries such as timber mining, hotel resort, housing land development and finance investment holding.He is the Executive Chairman of TCH Resources Group and also holds directorship in Wazlian Group, the Vice President of TA PAY Group as well as IBG Group.He also holds other chairmanships in several associations, President of Malaysia-China Chamber of Commerce (Kelantan Branch), Vice President of Malaysia-Guangzhou Investment Association, and Advisor to Hongkong Chamber of Commerce and ASEAN Chamber of Commerce (Thailand).Currently, Datuk Tan is the Vice President and Independent Non-Executive Director of Ikhmas Jaya Group Berhad. He is the Independent Non-Executive Director of Ni Hsin Resources Berhad and also the Vice President and Independent Non-Executive Director of Inix Technologies Holdings Berhad. He also act as the advisor of Gunung Capital Berhad and Vice Chairman of Gunung Resources Sdn Bhd, a wholly owned subsidiary of Gunung Capital Berhad. | Directorships in public companies and listed issuers (if any) | 1. Ni Hsin Resources Berhad2. Inix Technologies Holdings Berhad3. Ikhmas Jaya Group Berhad | Family relationship with any director and/or major shareholder of the listed issuer | Nil | Any conflict of interests that he/she has with the listed issuer | Nil | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct Interest - 8,880,000 ordinary shares |
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR "THE COMPANY")- Press Release : Helm of Metronic handed over to Datuk Tan Choon Hwa | Please find attached Metronic's press release entitled "HELM OF METRONIC HANDED OVER TO DATUK TAN CHOON HWA".
This announcement is dated 13 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3104746
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY")- MEMORANDUM OF AGREEMENT BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION AND METRONIC GLOBAL BERHAD | Please refer to the attachment. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3106939
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR "THE COMPANY")- Press Release : Metronic would be making RM180 million profit from Covid-19 vaccine | Please find attached Metronic's press release entitled "Metronic would be making RM180 million profit from Covid-19 vaccine".
This announcement is dated 20 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3106937
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-24112020-00001 | Subject | MEMORANDUM OF AGREEMENT BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION AND METRONIC GLOBAL BERHAD (METRONIC) (AGREEMENT) | Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY") - ADDITIONAL INFORMATION ON THE MEMORANDUM OF AGREEMENT BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION AND METRONIC GLOBAL BERHAD | Query Letter Contents | We refer to your Company’s announcement dated 20 November 2020, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:- - The relevant regulatory approvals required to be obtained before Metronic can commence the distributorship under the Finished Product Model and Fill and Distribution Model of MVC’s COVID-19 vaccine in Malaysia and the estimated time-frame for submission of such applications.
- The basis and assumptions in arriving at the financial forecast of RM180 million profit from Covid-19 vaccine.
Kindly note that this letter supersedes the query letter issued on 23 November 2020 on the same matter. | Please refer to the attachment. |
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2020 | 30 Sep 2019 | 30 Sep 2020 | 30 Sep 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 5,502 | 6,586 | 5,502 | 6,586 | | 2 | Profit/(loss) before tax | 3,386 | -227 | 3,386 | -227 | | 3 | Profit/(loss) for the period | 3,365 | -249 | 3,365 | -249 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,393 | -221 | 3,393 | -221 | | 5 | Basic earnings/(loss) per share (Subunit) | 0.41 | -0.03 | 0.41 | -0.03 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0800 | 0.0800
|
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | ESOS | Details of corporate proposal | Exercise of ESOS | No. of shares issued under this corporate proposal | 40,725,439 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.1026 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 1,286,515,931 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 137,175,645.061 | Listing Date | 07 Dec 2020 |
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY")- LETTER OF ACCEPTANCE FOR SUBCONTRACT WORKS FROM WCT TSR SDN BHD | Please refer to the attachment. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3113631
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY")- LETTER OF ACCEPTANCE FOR SUBCONTRACT WORKS FROM SAMSUNG C&T CORPORATION UEM CONSTRUCTION JV SDN BHD | Please refer to the attachment. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3113632
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT OF UP TO 373,737,000 NEW ORDINARY SHARES IN THE COMPANY, REPRESENTING 30% OF THE EXISTING TOTAL NUMBER OF ISSUED SHARES OF THE COMPANY, TO INDEPENDENT THIRD-PARTY INVESTOR(S) TO BE IDENTIFIED LATER AND AT AN ISSUE PRICE TO BE DETERMINED LATER ("PROPOSED PRIVATE PLACEMENT") | On behalf of the Board of Directors of the Company (“Board”), Mercury Securities Sdn Bhd (“Mercury Securities” or the “Principal Adviser” or the “Placement Agent”) wishes to announce that the Company proposes to undertake the private placement of up to 373,737,000 new ordinary shares in the Company (“Metronic Shares” or “Shares”), representing 30% of the existing total number of issued Shares, to independent third-party investor(s) to be identified later and at an issue price to be determined later (“Placement Shares”) (“Proposed Private Placement”).
Please refer to the attachment for further details on the Proposed Private Placement.
This announcement is dated 17 December 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3114719
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR "THE COMPANY")- TERMINATION OF MEMORANDUM OF AGREEMENT ("MOA") BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION ("MVC") AND METRONIC GLOBAL BERHAD | Reference is made to the Company’s announcement dated 20 November 2020 pertaining to the MOA entered between the Company and MVC to obtain exclusive distribution rights for MVC’s COVID-19 Vaccine.
The Board of Directors of Metronic wishes to announce that MGB and MVC had on 31 December 2020 mutually agreed to terminate the MOA with immediate effect.
This announcement is dated 5 January 2021. |
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-05012021-00003 | Subject | METRONIC GLOBAL BERHAD - TERMINATION OF MEMORANDUM OF AGREEMENT ("MOA") BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION ("MVC") AND METRONIC GLOBAL BERHAD | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR "THE COMPANY")- ADDITIONAL INFORMATION ON THE TERMINATION OF MEMORANDUM OF AGREEMENT ("MOA") BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION ("MVC") AND METRONIC GLOBAL BERHAD | Query Letter Contents | We refer to your Company’s announcement dated 5 January 2021, in respect of the aforesaid matter.
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-
1) To elaborate on the reason(s) for the termination of the MOA between the Company and MVC to obtain exclusive distribution rights for MVC’s COVID-19 vaccine.
2) It was stated in the Company’s press release dated 20 November 2020 that within a month after the signing of the MOA, Metronic Medicare Sdn Bhd shall deposit US$1.5 million with MVC and apply the refundable deposit to the purchase price of orders for the Finished Product. To state whether such amount has been deposited with MVC. If so, to state on whether such amount is refundable directly to the Company in view of the termination of the MOA. | We refer to METRONIC’s announcement dated 5 January 2021 (“Announcement”) in relation to the Termination of Memorandum of Agreement between Medigen Vaccine Biologics Corporation and Metronic Global Berhad, and query from Bursa Malaysia Securities Berhad ("Bursa Securities") vide its letter dated 5 January 2021 in relation to the same (“Bursa Queries”).
The Company wishes to announce the following as required by Bursa Securities:-
1. To elaborate on the reason(s) for the termination of the MOA between the Company and MVC to obtain exclusive distribution rights for MVC’s COVID-19 vaccine.
The MOA was terminated because the deposit of US$1.5 million was not paid to MVC within the agreed timeframe.
2. It was stated in the Company’s press release dated 20 November 2020 that within a month after the signing of the MOA, Metronic Medicare Sdn Bhd shall deposit US$1.5 million with MVC and apply the refundable deposit to the purchase price of orders for the Finished Product. To state whether such amount has been deposited with MVC. If so, to state on whether such amount is refundable directly to the Company in view of the termination of the MOA.
No deposit was paid to MVC.
This announcement is dated 6 January 2021.
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-8-2021 07:48 AM
|
显示全部楼层
本帖最后由 icy97 于 25-10-2021 08:18 AM 编辑
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR "THE COMPANY")- TERMINATION OF MEMORANDUM OF AGREEMENT ("MOA") BETWEEN MEDIGEN VACCINE BIOLOGICS CORPORATION ("MVC") AND METRONIC GLOBAL BERHAD | Reference is made to the Company’s announcements dated 5 January 2021 and 6 January 2021 pertaining to the termination of MOA entered between the Company and MVC to obtain exclusive distribution rights for MVC’s COVID-19 Vaccine.
The Board of Directors of Metronic wishes to further clarify that the deposit of US$1.5 million was not paid to MVC within the agreed timeframe, as both the parties were of the opinion that it is not viable to proceed with the proposed distribution agreement based on the announcement made by Ministry of Health of Malaysia on 17 December 2020, that the government will purchase the COVID-19 vaccines directly from the suppliers.
This announcement is dated 7 January 2021. |
Type | Reply to Query | Reply to Bursa Malaysia's Query Letter - Reference ID | IQL-03022021-00001 | Subject | JOINT RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN METRONIC MEDICARE SDN. BHD., THE WHOLLY-OWNED SUBSIDIARY OF METRONIC AND JOYSBIO (TIANJIN) BIOTECHNOLOGY CO.,LTD | Description | METRONIC'S RESPONSE TO BURSA SECURITIES' QUERIES | Query Letter Contents | We refer to your Company’s announcement dated 2 February 2021, in respect of the aforesaid matter. In this connection, kindly furnish Bursa Securities with the following additional information for public release:- - To state the identity of the major shareholders of Joysbio.
- To elaborate on the rationale and expected outcome of the Project.
- To state the relevant authorities’ approvals required to produce and distribute the SARS-Cov-2 Neutralising Antibody Test Kit.
- It is noted that Joysbio shall provide MMSB a written program reports periodically and a final report not later than two (2) months from the end of the Contract Period. To elaborate on the details of the said written program reports and how will MMSB benefit from this arrangement.
- It is noted that the first initial payment shall be USD 1,000,000 (equivalent to RM4,042,500). To state whether such amount has been paid.
- To state the basis to arrive at MMSB’s maximum liability for the Project of USD 2,000,000 and the nature of expenses to be incurred by Joysbio under the Project.
- To provide examples of events of that could constitute to early termination of the Project by both Parties pursuant to the Agreement.
- It is noted that MMSB shall pay all costs incurred in connection with the research, development and production cost for the first 800,000 units. To provide the estimated amount for such costs and the source of funds, and whether the initial payment of USD1 million constitutes part of this cost.
- To further elaborate on the statement in Section 3(vi) of the announcement which reads “Joysbio shall be responsible for, and liable to able employee-inventor regarding, its employee inventor’s reward relating to the benefits of any Joint Intellectual Property. Joysbio shall indemnify MMSB for any such claim by any of the Joysbio’s employees.”
| Reference is made to METRONIC’s announcement dated 2 February 2021 (“Announcement”) in relation to the Joint Research and Development Agreement between Metronic Medicare Sdn. Bhd. and Joysbio (Tianjin) Biotechnology Co. Ltd, and queries from Bursa Malaysia Securities Berhad ("Bursa Securities") vide its letter dated 3 February 2021 in relation to the same (“Bursa Queries”).
Please see attachment for further information. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3126872
|
|
|
|
|
|
|
|
|
|
|
|
发表于 16-10-2021 12:04 PM
|
显示全部楼层
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD ("METRONIC" or "THE COMPANY")1) MEMORANDUM OF AGREEMENT BETWEEN METRONIC AND EARTHTECH ENERGY SDN BHD (FORMERLY KNOWN AS DEHUI ENERGY (M) SDN BHD) FOR A SOLAR POWER PURCHASE PROJECT2) PRESS RELEASE : METRONIC TURNING INTO A MAJOR PLAYER IN COMMERCIAL PROPERTIES SOLAR POWER GENERATION | The Board of Directors of Metronic is pleased to announce that the Company had on 1 July 2021 (“Effective Date”) entered into a Memorandum of Agreement (“MOA”) with Earthtech Energy Sdn Bhd (Formerly known as Dehui Energy (M) Sdn Bhd) (“ET”) (collectively with Metronic, to be referred as the “Parties”) to regulate their working relationship in the formation of a joint venture for the Solar Power Purchase Project, subject to the terms and conditions in the MOA.
Please refer to the attachment and press release for further details.
This announcement is dated 2 July 2021 |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3172282
Type | Announcement | Subject | OTHERS | Description | METRONIC GLOBAL BERHAD (METRONIC or THE COMPANY)SUBSCRIPTION AND JOINT VENTURE AGREEMENT BETWEEN METRONIC AND EARTHTECH ENERGY SDN BHD AND MR CHEW KENG YAW | Reference is made to the Company’s announcement dated 2 July 2021 in relation to the Memorandum of Agreement entered between the Company with Earthtech Energy Sdn Bhd (“ET”) (collectively with the Company, to be referred as the “Parties” or “Shareholders”).
The Board of Directors of Metronic is pleased to announce that the Company had on 15 October 2021 entered into a Subscription and Joint Venture Agreement (“the SJV Agreement”) with ET and Mr Chew Keng Yaw to regulate their joint venture arrangement to undertake the business activities of carrying out the design, research and development, production and/or installation of solar power equipment to be marketed and sold as well as to provide after-sales services support thereafter.
Please refer to the attachment for further details.
This announcement is dated 15 October 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3201436
|
|
|
|
|
|
|
|
|
|
|
|
发表于 30-12-2021 09:44 AM
|
显示全部楼层
Type | Announcement | Subject | MULTIPLE PROPOSALS | Description | METRONIC GLOBAL BERHAD ("METRONIC" OR THE "COMPANY")(I) PROPOSED DIVERSIFICATION;(II) PROPOSED SHARE CONSOLIDATION; AND(III) PROPOSED RIGHTS ISSUE WITH WARRANTS(COLLECTIVELY REFERRED TO AS THE "PROPOSALS") | On behalf of the Board of Directors of the Company, Mercury Securities Sdn Bhd (“Mercury Securities” or the “Principal Adviser”) wishes to announce that the Company proposes to undertake the following:-
(i) proposed diversification of the existing business of Metronic and its subsidiaries (“Metronic Group” or the “Group”) to include the design, research and development, installation, engineering, procurement, construction, commissioning and maintenance of solar PV panels, equipment and facilities and other related activities including solar leasing (“Solar Energy Business”) (“Proposed Diversification”);
(ii) proposed consolidation of every 10 existing ordinary shares in Metronic (“Metronic Shares” or “Shares”) into 1 Share (“Consolidated Share”) (“Proposed Share Consolidation”); and
(iii) proposed renounceable rights issue of up to 1,742,433,306 new Shares (“Rights Shares”) together with up to 580,811,102 free detachable warrants in the Company (“Warrants B”) on the basis of 6 Rights Shares together with 2 free Warrants B for every 1 Consolidated Share held by the entitled shareholders of the Company on an entitlement date to be determined (“Entitlement Date”) (“Entitled Shareholders”) (“Proposed Rights Issue with Warrants”).
Please refer to the attachment for further details on the above.
This announcement is dated 19 November 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3210909
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-2-2022 10:17 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2021 | 30 Sep 2020 | 30 Sep 2021 | 30 Sep 2020 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 6,807 | 5,502 | 6,807 | 5,502 | | 2 | Profit/(loss) before tax | -78 | 3,527 | -78 | 3,527 | | 3 | Profit/(loss) for the period | -78 | 3,365 | -78 | 3,365 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -76 | 3,393 | -76 | 3,393 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.01 | 0.41 | -0.01 | 0.41 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0600 | 0.0700
|
|
|
|
|
|
|
|
|
|
|
|
|
发表于 12-9-2022 09:37 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | FITTERS PROPERTY DEVELOPMENT SDN BHD | Address | c/o Third Floor, No. 77, 79 & 81
Jalan SS 21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia. | Company No. | 199601040555 (412908-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 07 Sep 2022 | 74,000,000 | Disposed | Direct Interest | Name of registered holder | FITTERS PROPERTY DEVELOPMENT SDN. BHD. | Address of registered holder | Wisma FITTERS No. 1, Jalan Tembaga SD 5/2 Bandar Sri Damansara 52200 Kuala Lumpur Wilayah Persekutuan | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 74,000,000 shares via open market. | Nature of interest | Direct Interest | Direct (units) | 116,723,300 | Direct (%) | 7.624 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 116,723,300 | Date of notice | 09 Sep 2022 | Date notice received by Listed Issuer | 09 Sep 2022 |
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | FITTERS PROPERTY DEVELOPMENT SDN BHD | Address | c/o Third Floor, No. 77, 79 & 81
Jalan SS 21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia. | Company No. | 199601040555 (412908-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | FITTERS PROPERTY DEVELOPMENT SDN BHD | Address of registered holder | Wisma FITTERS, No. 1, Jalan Tembaga SD 5/2, Bandar Sri Damansara, 52200 Kuala Lumpur, Wilayah Persekutuan. | Date of cessation | 08 Sep 2022 |
No of securities disposed | 50,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of 50,000,000 shares via open market. | Nature of interest | Direct Interest |  | Date of notice | 09 Sep 2022 | Date notice received by Listed Issuer | 09 Sep 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 14-9-2022 09:30 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | BC MEDICARE SDN BHD | Address | Third Floor, No. 77, 79 & 81
Jalan SS21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia. | Company No. | 202101001086 (1401384-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 08 Aug 2022 | 20,000,000 | Disposed | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 2 | 09 Aug 2022 | 4,000,000 | Acquired | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 3 | 10 Aug 2022 | 2,500,000 | Disposed | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 4 | 11 Aug 2022 | 1,500,000 | Disposed | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 5 | 08 Sep 2022 | 5,000,000 | Acquired | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 6 | 08 Sep 2022 | 1,334,100 | Disposed | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | | | 7 | 09 Sep 2022 | 3,665,900 | Disposed | Direct Interest | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | 1. Acquisition of 4,000,000 shares via open market.2. Acquisition of 5,000,000 shares via off market.3. Disposal of 29,000,000 shares via off market. | Nature of interest | Direct Interest | Direct (units) | 96,500,000 | Direct (%) | 6.303 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 96,500,000 | Date of notice | 13 Sep 2022 | Date notice received by Listed Issuer | 13 Sep 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-9-2022 09:07 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | BC MEDICARE SDN BHD | Address | Third Floor, No. 77, 79 & 81
Jalan SS21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia. | Company No. | 202101001086 (1401384-X) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | BC MEDICARE SDN. BHD. | Address of registered holder | Third Floor, No. 77, 79 & 81, Jalan SS21/60, Damansara Utama, 47400 Petaling Jaya, Selangor Darul Ehsan. | Date of cessation | 14 Sep 2022 |
No of securities disposed | 96,500,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of shares via off market. | Nature of interest | Direct Interest | | Date of notice | 19 Sep 2022 | Date notice received by Listed Issuer | 19 Sep 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-9-2022 09:07 AM
|
显示全部楼层
Particulars of substantial Securities HolderName | SANICHI TECHNOLOGY BERHAD | Address | Unit 27.2, Menara 1MK
Kompleks 1 Mont Kiara
No. 1 Jalan Kiara, Mont Kiara
KUALA LUMPUR
50480 Wilayah Persekutuan
Malaysia. | Company No. | 200401023320 (661826-K) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 13 Sep 2022 | 84,000,000 | Disposed | Direct Interest | Name of registered holder | SANICHI TECHNOLOGY BERHAD | Address of registered holder | UNIT 27.2, MENARA 1MK, KOMPLEKS 1 MONT KIARA, NO. 1, JALAN KIARA, MONT KIARA, 50480 KUALA LUMPUR. | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Disposal of 84,000,000 shares via open market. | Nature of interest | Direct Interest | Direct (units) | 114,166,666 | Direct (%) | 7.457 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 114,166,666 | Date of notice | 19 Sep 2022 | Date notice received by Listed Issuer | 19 Sep 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 22-9-2022 08:45 AM
|
显示全部楼层
Notice of Person Ceasing (Section 139 of CA 2016)Particulars of Substantial Securities HolderName | SANICHI TECHNOLOGY BERHAD | Address | Unit 27.2, Menara 1MK
Kompleks 1 Mont Kiara
No. 1 Jalan Kiara, Mont Kiara
Kuala Lumpur
50480 Wilayah Persekutuan
Malaysia. | Company No. | 200401023320 (661826-K) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | SANICHI TECHNOLOGY BERHAD | Address of registered holder | Unit 27.2, Menara 1MK, Kompleks 1 Mont Kiara, No. 1 Jalan Kiara, Mont Kiara, 50480 Kuala Lumpur. | Date of cessation | 14 Sep 2022 |
No of securities disposed | 64,000,000 | Circumstances by reason of which a person ceases to be a substantial shareholder | Disposal of shares via open market. | Nature of interest | Direct Interest | | Date of notice | 15 Sep 2022 | Date notice received by Listed Issuer | 21 Sep 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 11-10-2022 06:34 PM
|
显示全部楼层
Information Compiled By KLSE Particulars of DirectorName | DATO' KUA KHAI SHYUAN | Descriptions(Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of transaction | Nature of Interest | | 1 | 07/09/2022 | 25,000,000 | Acquired | Direct Interest | Name of registered holder | DATO' KUA KHAI SHYUAN | Description of "Others" Type of Transaction | | Consideration (if any) | RM0.0774 |
Circumstances by reason of which change has occurred | Acquisition of shares | Nature of interest | Direct Interest |
| Total no of securities after change | Direct (units) | 25,033,333 | Direct (%) | 1.635 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0.000 | Date of notice | 07/10/2022 | Date notice received by Listed Issuer | 07/10/2022 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 15-4-2024 11:08 PM
|
显示全部楼层
Change in Financial Year End
Old financial year end | 30 Jun 2024 | New financial year end | 31 Oct 2024 |
| Remarks : | | The change in the financial year end of the Company from 30 June to 31 October to allow the Company to avoid the peak financial reporting in June and enable better resource management, coordination and streamline its annual financial reporting in the future. |
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
3642 
63
